Author: Admin

Intracerebroventricular (ICV) injection is a direct delivery method that introduces genetic material or therapeutic agents into the cerebrospinal fluid (CSF) within the brain’s ventricles. This approach bypasses the blood-brain barrier and allows widespread distribution of vectors or nucleic acids throughout the central nervous system. ICV injection is widely used in experimental neuroscience for transfecting neonatal…

Lipid nanoparticles (LNPs) have become the leading non-viral platform for delivering mRNA therapeutics, including vaccines and gene editing components. Their ability to encapsulate and protect fragile mRNA, facilitate cellular uptake, and promote endosomal escape has revolutionized gene delivery technology. However, delivering LNP-encapsulated mRNA to brain tissue presents unique challenges due to the protective blood-brain barrier…

Stereotaxic transfection is a powerful technique for delivering genetic material precisely into deep brain regions that are otherwise difficult to access. By combining precise coordinates with microinjection and gene delivery tools, researchers can introduce plasmids, viral vectors, or nanoparticles into areas such as the hippocampus, striatum, or thalamus. This method is essential for studying localized…

Achieving cell-type specificity in brain transfection is critical for unraveling the diverse functions of distinct neural populations and minimizing off-target effects in gene therapy applications. The choice of promoter that drives transgene expression strongly influences which cells within the central nervous system (CNS) will produce the protein of interest after gene delivery. While ubiquitous promoters…

Delivering small interfering RNA (siRNA) to the central nervous system (CNS) holds great promise for silencing disease-related genes in neurodegenerative disorders, brain tumors, and neuroinflammatory conditions. However, effective delivery of siRNA to brain cells is challenging due to its instability, negative charge, and inability to cross the blood-brain barrier (BBB). Polymeric micelles and dendrimers have…

Microglia are the primary immune cells of the central nervous system and play key roles in homeostasis, synaptic pruning, and neuroinflammation. Despite their importance in neurobiology and brain pathology, transfecting microglia in vivo remains a formidable challenge. These cells possess an active endolysosomal system, rapidly degrade foreign nucleic acids, and are highly responsive to pattern…

CRISPR/Cas9 genome editing has revolutionized neuroscience by enabling targeted manipulation of genes involved in brain development, function, and disease. Delivering CRISPR components into brain tissue, however, presents technical and biological challenges that are not present in standard in vitro systems. Achieving efficient on-target editing in neurons and glial cells requires precise delivery of Cas9 and…

Electroporation has emerged as a valuable method for non-viral gene delivery to the rodent brain, particularly in applications where high spatial precision and transient expression are required. By applying brief, high-voltage electrical pulses, this technique temporarily permeabilizes cell membranes, allowing plasmid DNA, mRNA, or other nucleic acids to enter the cytoplasm. When applied to the…

In brain transfection research, accurate quantification of gene delivery and expression is essential for validating experimental success and understanding spatial distribution within neural tissue. Traditional histological methods, while informative, are often invasive, endpoint-based, and time-consuming. Advances in in vivo imaging—particularly bioluminescence and multiplexed fluorescent reporter systems—have transformed how researchers monitor transfection outcomes in the brain….

Delivering genetic material across the blood–brain barrier (BBB) presents one of the most persistent challenges in central nervous system research. The BBB is highly selective, preventing most macromolecules, including DNA and RNA-based therapeutics, from entering the brain parenchyma. While viral vectors like AAVs have demonstrated some success, non-viral nanocarriers have gained increasing interest due to…